论文部分内容阅读
目的研究分析疏血通和阿司匹林联合用药对进展型脑梗死患者的治疗效果。方法根据我院2011~2014年的82例进展型脑梗死患者来分析研究,将这些患者分组为对照组41例,观察组41例,观察组使用疏血通和大剂量阿司匹林联合治疗,对照组使用曲克芦丁与小剂量阿司匹林联合治疗。对两组患者治疗15天的效果进行比较分析。结果观察组的临床有效率是92.68%,对照组的有效率是73.17%,P<0.05。两组患者的红细胞比容、血小板聚集率、血浆比黏度等均低于治疗前,P<0.05,观察组的血小板聚集率比对照组低,P<0.05。两组的凝血指标治疗前后无差异性。此次研究中没有出现不良反应病例。结论进展型脑梗死患者在发病初期使用疏血通和大剂量阿司匹林的治疗方式效果突出,安全可靠,临床中应用效果好,应用价值高。
Objective To study and analyze the therapeutic effect of Shuxuetong and aspirin combination therapy on patients with progressive cerebral infarction. Methods According to 82 cases of progressive cerebral infarction in our hospital from 2011 to 2014, the patients were divided into control group (41 cases) and observation group (41 cases). The observation group was treated with Shuxuetong and high-dose aspirin, and the control group The use of troxerutin and low-dose aspirin combination therapy. Two groups of patients treated for 15 days comparative analysis of the effect. Results The clinical effective rate was 92.68% in the observation group and 73.17% in the control group, P <0.05. The hematocrit, platelet aggregation rate and plasma viscosity of the two groups were lower than those before treatment, P <0.05. The platelet aggregation rate in the observation group was lower than that in the control group (P <0.05). There was no difference in coagulation index between the two groups before and after treatment. There were no adverse reactions in this study. Conclusion The treatment of patients with progressive cerebral infarction at the initial stage of the disease using Shuxuetong and high-dose aspirin treatment is outstanding, safe and reliable, clinical application of effective, high value.